Peapack-Gladstone Financial Corp’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$174K Buy
+10,400
New +$174K ﹤0.01% 651
2025
Q1
Sell
-10,677
Closed -$235K 722
2024
Q4
$235K Sell
10,677
-590
-5% -$13K ﹤0.01% 614
2024
Q3
$203K Sell
11,267
-4,176
-27% -$75.2K ﹤0.01% 656
2024
Q2
$251K Sell
15,443
-10,720
-41% -$174K ﹤0.01% 592
2024
Q1
$369K Sell
26,163
-12,827
-33% -$181K 0.01% 535
2023
Q4
$407K Sell
38,990
-17,518
-31% -$183K 0.01% 520
2023
Q3
$576K Sell
56,508
-11,791
-17% -$120K 0.01% 450
2023
Q2
$514K Sell
68,299
-5,411
-7% -$40.7K 0.01% 478
2023
Q1
$652K Sell
73,710
-5,392
-7% -$47.7K 0.01% 431
2022
Q4
$721K Sell
79,102
-2,251
-3% -$20.5K 0.01% 414
2022
Q3
$657K Buy
81,353
+4,071
+5% +$32.9K 0.01% 420
2022
Q2
$581K Buy
77,282
+3,106
+4% +$23.4K 0.01% 425
2022
Q1
$697K Buy
74,176
+16,685
+29% +$157K 0.01% 416
2021
Q4
$461K Buy
57,491
+7,429
+15% +$59.6K 0.01% 483
2021
Q3
$488K Buy
50,062
+5,024
+11% +$49K 0.01% 470
2021
Q2
$446K Sell
45,038
-627
-1% -$6.21K 0.01% 439
2021
Q1
$527K Buy
+45,665
New +$527K 0.01% 401
2016
Q1
Sell
-4,205
Closed -$276K 335
2015
Q4
$276K Sell
4,205
-251
-6% -$16.5K 0.02% 281
2015
Q3
$252K Sell
4,456
-550
-11% -$31.1K 0.02% 287
2015
Q2
$296K Sell
5,006
-315
-6% -$18.6K 0.02% 270
2015
Q1
$331K Buy
5,321
+1
+0% +$62 0.02% 264
2014
Q4
$306K Sell
5,320
-285
-5% -$16.4K 0.02% 258
2014
Q3
$301K Buy
5,605
+200
+4% +$10.8K 0.02% 250
2014
Q2
$283K Buy
5,405
+470
+10% +$24.6K 0.02% 256
2014
Q1
$261K Sell
4,935
-700
-12% -$37K 0.02% 265
2013
Q4
$226K Sell
5,635
-40
-0.7% -$1.6K 0.02% 269
2013
Q3
$214K Sell
5,675
-4,450
-44% -$168K 0.02% 270
2013
Q2
$397K Buy
+10,125
New +$397K 0.04% 216